Studii de supravietuire in oncologia pediatrica din Romania

Survival studies in paediatric oncology in Romania

Our experts carried out two survival studies, in 2019 and 2024, based on data from the National Paediatric Onco-Haematology Registry. Both have been validated by experts from the European Network of Cancer Registries.

Completed

15.02.2024 – Palatul Parlamentului – Presentation of the second survival study

Survival studies in paediatric cancer are carried out worldwide on the basis of cancer registries.

Registrul Național de Onco-Hematologie Pediatrică in our country is a joint project of Asociația Dăruiește Aripi and Societatea Română de Onco-Hematologie Pediatrică.

We can say that we have a complete and valid survival analysis of children with cancer in Romania, an essential step in aligning our country with international standards.

2019 survival study

Five-year survival from the date of diagnosis for cases diagnosed between 2010 – 2013 was 69.4% for the 0-14 age group, in line with the average for Eastern European countries, but 10% lower than the average for Western European countries. 

Study report

2024 survival study

Five-year survival, from the date of diagnosis for cases diagnosed between 2014 – 2017 is 74% for the 0-14 age group, the European Union average being 81%, and the Eastern Europe average 71% (according to EUROCARE 6).

Study report